📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis. (2015)

First Author: Boeree MJ

Attributed to: Tuberculosis Treatment Trials funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201407-1264oc

PubMed Identifier: 25654354

Publication URI: http://europepmc.org/abstract/MED/25654354

Type: Journal Article/Review

Volume: 191

Parent Publication: American journal of respiratory and critical care medicine

Issue: 9

ISSN: 1073-449X